- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Exocrine Pancreatic Insufficiency
Total 39888 results
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...The First Affiliated Hospital with Nanjing Medical University; Fudan University and other collaboratorsNot yet recruitingPancreatic CarcinomaChina
-
Sonke DetlefsenKarolinska Institutet; University Hospital Schleswig-Holstein; Martin-Luther-Universität...RecruitingPancreatic Cancer | Pancreatic AdenocarcinomaDenmark
-
Benaroya Research InstituteRecruitingPancreatic AdenocarcinomaUnited States
-
Golden Biotechnology CorporationCovanceActive, not recruitingPancreatic NeoplasmUnited States, Korea, Republic of, Taiwan
-
Sidney Kimmel Comprehensive Cancer Center at Johns...The Skip Viragh FoundationActive, not recruiting
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Changhai HospitalCompleted
-
Eli Lilly and CompanyCompletedPancreatic NeoplasmUnited States
-
Shanghai Proton and Heavy Ion CenterCompletedPancreatic CarcinomaChina
-
AdventHealthCompletedPancreatic Neoplasms | Pancreatic Cancer | Pancreatic AdenocarcinomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedPancreatic CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteReliable Cancer TherapiesCompleted
-
Yale UniversityRoche Pharma AG; National Comprehensive Cancer Network; PhytoCeuticaCompleted
-
University of LiverpoolAstraZenecaUnknownPancreatic CancerUnited Kingdom
-
Shyam VaradarajuluCompletedPancreatic TumorsUnited States
-
Health Science Center of Xi'an Jiaotong UniversityHuazhong University of Science and Technology; LinkDoc Technology (Beijing)...Not yet recruitingPancreatic Cancer Non-resectable
-
Fudan UniversityQilu Hospital of Shandong University; The Third Affiliated Hospital of Soochow...Not yet recruitingLeft-sided Pancreatic CancerChina
-
Amplia Therapeutics LimitedRecruitingACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic CancerPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | PDACAustralia, Korea, Republic of
-
Fudan UniversityWest China Hospital; Tongji Hospital; Qilu Hospital of Shandong University; Zhejiang... and other collaboratorsRecruitingBorderline Resectable Pancreatic CancerChina
-
Angiodynamics, Inc.RecruitingStage III Pancreatic CancerUnited States
-
Universita di VeronaSuspendedBorderline Resectable Pancreatic CancerItaly
-
University of LouisvilleJames Graham Brown Cancer CenterCompletedPancreatic Cancer Non-resectableUnited States
-
Kaiser PermanenteNational Cancer Institute (NCI)Active, not recruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma (PDAC)United States
-
Per PfeifferCompletedLocally Advanced Pancreatic CancerDenmark
-
German Cancer Research CenterHeidelberg UniversityCompletedPrimarily Resectable Pancreatic CancerGermany
-
Burzynski Research InstituteTerminatedStage IV Pancreatic CancerUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedPancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
National Taiwan University HospitalOno Pharmaceutical Co. Ltd; TTY Biopharm; ACT GenomicsUnknownStage IV Pancreatic Cancer
-
University of HawaiiWithdrawnMetastatic Pancreatic Cancer | ERCC1United States
-
Immunitor LLCUnknownPancreatic Cancer Non-resectableMongolia
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Vaximm GmbHCompletedStage IV Pancreatic CancerGermany
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; National Cheng-Kung University HospitalUnknownLocally Advanced Pancreatic Cancer
-
IpsenCompletedNon Functioning Entero-pancreatic Endocrine TumourUnited Kingdom, France, Spain, United States, Belgium, Czechia, Italy, Slovakia, Poland
-
City of Hope Medical CenterNational Cancer Institute (NCI); National Institute of Nursing Research (NINR)CompletedStage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic CancerUnited States
-
National Cancer Institute (NCI)TerminatedAdenocarcinoma of the Pancreas | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of UtahNovartis PharmaceuticalsRecruitingMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteJohns Hopkins University; M.D. Anderson Cancer Center; Mayo Clinic; University... and other collaboratorsActive, not recruitingCandidates for Hereditary Pancreatic Cancer TestingUnited States
-
Impatients N.V. trading as myTomorrowsImmodulon Therapeutics LtdNo longer availablePancreatic Cancer | Pancreatic Cancer Stage IV | Pancreas Cancer | Pancreatic Cancer Stage IIIFrance, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic AdenocarcinomaUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic Cancer | Stage I Pancreatic Cancer | Resectable Pancreatic Carcinoma | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Zhejiang UniversityNot yet recruitingResectable Pancreatic Adenocarcinoma
-
Abbisko Therapeutics Co, LtdRecruitingAdvanced Pancreatic CancerChina
-
Georgetown UniversityRecruitingMetastatic Pancreatic CancerUnited States
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingAdvanced Pancreatic CancerChina
-
SONIRE Therapeutics Inc.RecruitingUnresectable Pancreatic CancerJapan
-
Centre Leon BerardGlaxoSmithKlineRecruitingMetastatic Pancreatic CancerFrance
-
Fox Chase Cancer CenterRecruitingMetastatic Pancreatic CancerUnited States
-
Zhejiang Provincial People's HospitalHangzhou Neoantigen Therapeutics Co., Ltd.RecruitingResectable Pancreatic CancerChina